“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...

Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory ...

We recently published a list of 10 Firms End 2024 Stronger With Impressive Gains. In this article, we are going to take a ...

Moderna advances combo vaccine for flu and COVID-19 with trials starting in March Pharmaceutical companies gear up to tackle ...

With a state grand jury report released Wednesday, Florida Gov. Ron DeSantis doubled down on the message he delivered often ...

The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...

The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Discover CDC findings on COVID-19 variants and vaccine protection, revealing key insights into emerging strains and public ...

Earlier last year, the vaccine maker announced ... which covers a multi-year extension with Moderna (MRNA) to utilize Personalis’ ImmunoID NeXT Platform and technology for V940/mRNA-4157 ...